Anagenesis Biotechnologies' technology rewarded by the international scientific community through publication in Nature Biotechnology
  • 5
    Aug

Anagenesis Biotechnologies’ technology rewarded by the international scientific community through publication in Nature Biotechnology

  • Posted by:
  • Anagenesis

Anagenesis Biotechnologies announced today a key publication in Nature Biotechnology. The article is entitled “Differentiating embryonic stem cells to muscle fibers to model Duchenne Muscular Dystrophy” by Jérôme Chal et al. from the lab of Pr Olivier Pourquié (the two scientists inventors of Anagenesis Biotechnologies technology) together with co-authors from Anagenesis Biotechnologies.

Lean more in our press release:
PR publi Nat Biotech 2015
CP publi Nat Biotech 2015-3 FR

Our technology featured in the Harvard Gazette and on the front page of the Harvard website:
Harvard Gazette – Potential treatment for muscular dystrophy

Our technology featured on the AFM-Téléthon website:
Actualité AFM-Téléthon : “Première mondiale : du muscle « normal » à partir de cellules souches embryonnaires”
VLM N°174